Pregnancy Clinical Trial
Official title:
Using the Healthcare Visit to Improve Contraceptive Use
Consistent and correct use of an effective contraceptive method is a primary determinant in
preventing pregnancy. Unfortunately, only a minority of healthcare providers adequately
address women’s contraceptive needs. We have developed a standardized behavioral-based
contraceptive counseling model that can be used by providers and other clinic staff to
address this limitation. The model, ESP, is an adaptation of motivational interviewing and
involves: Exploring discrepancies between pregnancy intention and contraceptive use and
between risk of STDs and condom use; Sharing information; and Promoting behaviors to reduce
risk.
Study question: Does ESP counseling lead to an increase in consistency and effectiveness of
contraceptive use among women at risk of unintended pregnancy?
Methods: Randomized controlled trial of 747 women, ages 16-44, at self-identified risk of
unintended pregnancy enrolled from March 2003 to September 2004 at healthcare settings in
North Carolina. Intervention participants received individualized ESP counseling from a
health educator to address barriers to effective and consistent contraceptive use. Risk
reduction steps were negotiated. Pregnancy, Chlamydia infection and contraceptive use were
assessed at baseline and follow-up. “Highly effective” contraceptive use was defined as a
combination of effectiveness and consistency. Women in the control arm received general
preventive health counseling (e.g., smoking and exercise). Differences between the study
arms at 12-months may illustrate the longer term influence of the intervention.
Consistent and correct use of an effective contraceptive method is a primary determinant in
preventing pregnancy. Unfortunately, only a minority of healthcare providers adequately
address women’s contraceptive needs. We have developed a standardized behavioral-based
contraceptive counseling model that can be used by providers and other clinic staff to
address this limitation. The model, ESP, is an adaptation of motivational interviewing and
involves: Exploring discrepancies between pregnancy intention and contraceptive use and
between risk of STDs and condom use; Sharing information; and Promoting behaviors to reduce
risk.
Study question: Does ESP counseling lead to an increase in consistency and effectiveness of
contraceptive use among women at risk of unintended pregnancy?
Methods: Randomized controlled trial of 747 women, ages 16-44, at self-identified risk of
unintended pregnancy enrolled from March 2003 to September 2004 at healthcare settings in
North Carolina. Intervention participants received individualized ESP counseling from a
health educator to address barriers to effective and consistent contraceptive use. Risk
reduction steps were negotiated. Pregnancy, Chlamydia infection and contraceptive use were
assessed at baseline and follow-up. “Highly effective” contraceptive use was defined as a
combination of effectiveness and consistency. Women in the control arm received general
preventive health counseling (e.g., smoking and exercise). Differences between the study
arms at 12-months may illustrate the longer term influence of the intervention.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Educational/Counseling/Training
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |